Location: Seoul, Korea, Republic of
CIK: 0001710065 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 10, 2021
Total Value: $155M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVIR | ATEA PHARMACEUTICALS INC | 1,637,331 | $57.41M | 37.0% | $32.23 | -14.0% | COM | 04683R106 |
| KYMR | KYMERA THERAPEUTICS INC | 639,059 | $37.54M | 24.2% | $48.78 | +18.8% | COM | 501575104 |
| SEER | SEER INC | 816,375 | $28.19M | 18.2% | $63.62 | -45.9% | COM CL A | 81578P106 |
| APLS | APELLIS PHARMACEUTICALS INC | 624,962 | $20.6M | 13.3% | $42.30 | +32.8% | COM | 03753U106 |
| — | SUTRO BIOPHARMA INC | 175,000 | $3.306M | 2.1% | $21.71 | — | COM | 869367102 |
| — | RAPT THERAPEUTICS INC | 99,503 | $3.09M | 2.0% | $19.75 | — | COM | 75382E109 |
| — | CLEARSIDE BIOMEDICAL INC | 293,555 | $1.761M | 1.1% | $2.74 | — | COM | 185063104 |
| — | MOLECULAR TEMPLATES INC | 204,809 | $1.374M | 0.9% | $9.39 | — | COM | 608550109 |
| — | KEZAR LIFE SCIENCES INC | 128,916 | $1.114M | 0.7% | $5.22 | — | COM | 49372L100 |
| — | AILERON THERAPEUTICS INC | 517,558 | $528K | 0.3% | $1.04 | — | COM | 00887A105 |
| — | BELLICUM PHARMACEUTICALS INC | 25,651 | $75,000 | 0.0% | $3.55 | — | COM NEW | 079481404 |